← All countries · Americas
78.2%
MCV1
2025 · Administrative (country-reported)
76.6%
DTP3
2025 · Administrative (country-reported)
76.6%
IPV complete
2025 · Administrative (country-reported)
53.9%
HepB3
2025 · Administrative (country-reported)
0
Measles cases
2025 reported
4
Pertussis (whooping cough) cases
2025 reported
Two kinds of number live on this page. Coverage is the share of the target cohort vaccinated, as estimated by WHO and UNICEF each July from the country's reports, surveys and other evidence, shown beside what the country itself reported. Reported cases are what the national surveillance system sent to WHO; they are a floor, not a count of infections. Every row carries a grade; hover or focus it for the reason, or read how grades are assigned.
Vaccination coverage
| Vaccine | Latest estimate | Country-reported | Trend since 2000 | Data quality |
|---|---|---|---|---|
| BCGTuberculosis vaccine at birth | —% · Administrative (country-reported) | — | too few points | no data |
| DTP1First dose of diphtheria-tetanus-pertussis | 93.5%2025 · Administrative (country-reported) | 93.5% | D · poor | |
| DTP3Third dose of diphtheria-tetanus-pertussis (the WHO benchmark of a working programme) | 76.6%2025 · Administrative (country-reported) | 76.6% | D · poor | |
| IPV1First dose of inactivated polio vaccine | 93.5%2025 · Administrative (country-reported) | 93.5% | D · poor | |
| IPV completeInactivated polio vaccine, complete primary series | 76.6%2025 · Administrative (country-reported) | 76.6% | D · poor | |
| MCV1First dose of measles-containing vaccine | 78.2%2025 · Administrative (country-reported) | 78.2% | D · poor | |
| MCV2Second dose of measles-containing vaccine | 97.5%2025 · Administrative (country-reported) | 97.5% | D · poor | |
| RCV1First dose of rubella-containing vaccine | 78.2%2025 · Administrative (country-reported) | 78.2% | D · poor | |
| HepB3Third dose of hepatitis B vaccine | 53.9%2025 · Administrative (country-reported) | 53.9% | D · poor | |
| HepB birthHepatitis B birth dose within 24 hours | —% · Administrative (country-reported) | — | too few points | no data |
| Hib3Third dose of Haemophilus influenzae type b vaccine | 76.6%2025 · Administrative (country-reported) | 76.6% | D · poor | |
| PCV1Pneumococcal conjugate vaccine, first dose | 93.5%2025 · Administrative (country-reported) | 93.5% | D · poor | |
| PCV completePneumococcal conjugate vaccine, final dose of the schedule | 76.6%2025 · Administrative (country-reported) | 76.6% | D · poor | |
| RotaCRotavirus vaccine, complete series | 78.4%2025 · Administrative (country-reported) | 78.4% | D · poor | |
| Yellow feverYellow fever vaccine (countries at risk) | 34.8%2021 · Administrative (country-reported) | 34.8% | too few points | D · poor |
| MenAMeningococcal A conjugate (meningitis belt) | —% · Administrative (country-reported) | — | too few points | no data |
| JEJapanese encephalitis vaccine (countries at risk) | —% · Administrative (country-reported) | — | too few points | no data |
| TCVTyphoid conjugate vaccine | 93.8%2021 · Administrative (country-reported) | 93.8% | too few points | D · poor |
| PABProtection at birth against neonatal tetanus (maternal tetanus doses) | —% · Administrative (country-reported) | — | too few points | no data |
Reported vaccine-preventable disease
| Disease | Reported cases | Incidence rate | Trend since 2000 | Data quality |
|---|---|---|---|---|
| Measles all countries · vaccine evidence | 02025 | 0per 1,000,000 total population | B · good | |
| Rubella all countries · vaccine evidence | 02025 | 0per 1,000,000 total population | C · weak | |
| Congenital rubella syndrome all countries · vaccine evidence | 02025 | 0per 10,000 live births | C · weak | |
| Mumps all countries · vaccine evidence | 02025 | 0per 1,000,000 total population | B · good | |
| Pertussis (whooping cough) all countries · vaccine evidence | 42025 | 62per 1,000,000 total population | B · good | |
| Diphtheria all countries · vaccine evidence | 02025 | 0per 1,000,000 total population | C · weak | |
| Tetanus (total) all countries · vaccine evidence | 02025 | 0per 1,000,000 total population | B · good | |
| Neonatal tetanus all countries · vaccine evidence | 02025 | 0per 1,000 live births | C · weak | |
| Polio (paralytic) all countries · vaccine evidence | 02025 | 0per 1,000,000 <15 population | C · weak | |
| Yellow fever all countries · vaccine evidence | 02025 | 0per 1,000,000 total population | C · weak | |
| Japanese encephalitis all countries · vaccine evidence | 02019 | 0per 1,000,000 total population | too few points | D · poor |
| Invasive meningococcal disease all countries · vaccine evidence | 02025 | 0per 1,000,000 total population | D · poor | |
| Typhoid all countries · vaccine evidence | 02025 | 0per 1,000,000 total population | C · weak |
National schedule (latest WHO listing)
Show the schedule (77 rows)
| Vaccine | Dose | Age | Target group | Comment |
|---|---|---|---|---|
| CHOLERACholera vaccine | 1 | 1st contact | Travellers | Specific travel requirement for some travellers e.g. Raleigh International students |
| CHOLERACholera vaccine | 2 | +W2 | Travellers | Specific travel requirement for some travellers e.g. Raleigh International students |
| COVID19COVID-19 vaccine | 1 | Adults | All adults, all older adults | |
| COVID19COVID-19 vaccine | 1 | Health workers | Health and care workers | |
| COVID19COVID-19 vaccine | 1 | Risk group(s) | Children and adolescents with chronic conditions, adults with chronic conditions, older adults with chronic conditions | |
| DTAPHIBIPVDTaP-Hib-IPV (acellular) vaccine | 1 | M2 | General/routine | |
| DTAPHIBIPVDTaP-Hib-IPV (acellular) vaccine | 2 | M4 | General/routine | |
| DTAPHIBIPVDTaP-Hib-IPV (acellular) vaccine | 3 | M6 | General/routine | |
| DTAPHIBIPVDTaP-Hib-IPV (acellular) vaccine | 4 | M18 | General/routine | |
| DTAPIPVDTaP-IPV (acellular) vaccine | 5 | Y4-Y6 | General/routine | |
| HEPA_ADULTAdult Hepatitis A (HepA) vaccine | 1 | 1st contact | Travellers | Travellers |
| HEPA_ADULTAdult Hepatitis A (HepA) vaccine | 2 | +M6-M12 | Travellers | Travellers |
| HEPA_PEDIATRICPediatric Hepatitis A (HepA) vaccine | 1 | 1st contact | Travellers | Travellers |
| HEPA_PEDIATRICPediatric Hepatitis A (HepA) vaccine | 2 | +M6-M12 | Travellers | Travellers |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 1 | 1st contact | Health workers | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 1 | 1st contact | Risk group(s) | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 1 | 1st contact | Travellers | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 2 | +M1 | Health workers | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 2 | +M1 | Risk group(s) | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 2 | +M1 | Travellers | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 3 | +M6 | Health workers | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 3 | +M6 | Risk group(s) | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_ADULTAdult Hepatitis B (HepB) vaccine | 3 | +M6 | Travellers | Occupational (health care workers, police and Trash collectors), high risk adults, travelers. |
| HEPB_PEDIATRICPediatric Hepatitis B (HepB) vaccine | 1 | M6 | General/routine | 6/12 Month old infants |
| HEPB_PEDIATRICPediatric Hepatitis B (HepB) vaccine | 2 | M7 | General/routine | 6/12 Month old infants |
| HEPB_PEDIATRICPediatric Hepatitis B (HepB) vaccine | 3 | M12 | General/routine | 6/12 Month old infants |
| HIBHib (Haemophilus influenzae type B) vaccine | 1 | 1st contact | Risk group(s) | High risk adults for revaccination |
| HPV4HPV-4 (Human papillomavirus 4-valent) vaccine | 1 | Y10 | HPV administered to females and males | females and males; x2 doses for <15 years, x3 doses for >15 years, and also available for other adults upon request |
| HPV4HPV-4 (Human papillomavirus 4-valent) vaccine | 1 | 1st contact | Risk group(s) | 15- 45 Y - 2 doses and 3 doses for immunocompromised clients |
| HPV4HPV-4 (Human papillomavirus 4-valent) vaccine | 2 | +M6 | HPV administered to females and males | females and males; x2 doses for <15 years, x3 doses for >15 years, and also available for other adults upon request |
| HPV4HPV-4 (Human papillomavirus 4-valent) vaccine | 2 | +M6-M12 | Risk group(s) | 15- 45 Y - 2 doses and 3 doses for immunocompromised clients |
| INFLUENZA_ADULTAdult seasonal influenza vaccine | 1 | >Y18 | Adults | and older persons over 65 years |
| INFLUENZA_ADULTAdult seasonal influenza vaccine | 1 | Health workers | Health and care workers | |
| INFLUENZA_ADULTAdult seasonal influenza vaccine | 1 | Pregnant women | Pregnant women | |
| INFLUENZA_ADULTAdult seasonal influenza vaccine | 1 | Risk group(s) | Adults with chronic conditions, residents living in long-term care facilities | |
| INFLUENZA_PEDIATRICPediatric seasonal influenza vaccine | 1 | >=M6 | General/routine | |
| INFLUENZA_PEDIATRICPediatric seasonal influenza vaccine | 1 | Risk group(s) | Children with chronic conditions | |
| IPVIPV (Inactivated polio vaccine) | 1 | 1st contact | Risk group(s) | Unvaccinated travellers to high risk areas, or if required a booster dose |
| IPVIPV (Inactivated polio vaccine) | 1 | 1st contact | Travellers | Unvaccinated travellers to high risk areas, or if required a booster dose |
| JE_INACTDJE-Inact (Japanese Encephalitis inactivated) vaccine | 1 | 1st contact | Travellers | Travellers to high-risk areas |
| JE_INACTDJE-Inact (Japanese Encephalitis inactivated) vaccine | 2 | +D28 | Travellers | Travellers to high-risk areas |
| MEN_ACYW_135CONJMeningococcal ACYW conjugate vaccine | 1 | 1st contact | Risk group(s) | Adolescents (college bound students at age 18 and above), and travellers visiting high-risk areas |
| MEN_ACYW_135CONJMeningococcal ACYW conjugate vaccine | 1 | 1st contact | Travellers | Adolescents (college bound students at age 18 and above), and travellers visiting high-risk areas |
| MMRMMR (Measles, mumps and rubella) vaccine | 1 | M12 | General/routine | |
| MMRMMR (Measles, mumps and rubella) vaccine | 2 | M18 | General/routine | |
| MPOXMpox (monkeypox) vaccine | 1 | 1st contact | Risk group(s) | People who are at risk of catching the Mpox virus (e.g. men who have sex with men) |
| MPOXMpox (monkeypox) vaccine | 2 | +D28 | Risk group(s) | People who are at risk of catching the Mpox virus (e.g. men who have sex with men) |
| PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine | 1 | M2 | General/routine | |
| PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine | 2 | M4 | General/routine | |
| PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine | 3 | M6 | General/routine | |
| PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine | 4 | M18 | General/routine | |
| PPV23PPV-23 (Pneumococcal polysaccharide 23-valent) vaccine | 1 | 1st contact | Risk group(s) | High risk adults - Respiratory issues |
| RABIESRabies vaccine | 1 | 1st contact | Risk group(s) | Prevention for travellers at risk of exposure or post exposure |
| RABIESRabies vaccine | 1 | 1st contact | Travellers | Prevention for travellers at risk of exposure or post exposure |
| RABIESRabies vaccine | 2 | +D7 | Risk group(s) | Prevention for travellers at risk of exposure or post exposure |
| RABIESRabies vaccine | 2 | +D7 | Travellers | Prevention for travellers at risk of exposure or post exposure |
| ROTAVIRUS_1RV-1 (Rotavirus 1-valent) vaccine | 1 | M2 | General/routine | |
| ROTAVIRUS_1RV-1 (Rotavirus 1-valent) vaccine | 2 | M4 | General/routine | |
| TBE_ADULTAdult TBE (tick borne encephalitis) vaccine | 1 | 1st contact | Travellers | Travellers visiting high risk areas |
| TBE_ADULTAdult TBE (tick borne encephalitis) vaccine | 2 | +D14 | Travellers | Travellers visiting high risk areas |
| TBE_ADULTAdult TBE (tick borne encephalitis) vaccine | 3 | +M3 | Travellers | Travellers visiting high risk areas |
| TDAP_STdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine | 1 | +Y10 | Adults | Every 10 years, and it is given at 20 weeks gestational to pregnant mothers |
| TDAP_STdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine | 1 | 1st contact | Pregnant women | Every 10 years, and it is given at 20 weeks gestational to pregnant mothers |
| TDAP_STdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine | 6 | Y16 | General/routine | |
| TD_STd (Tetanus toxoid and diphtheria for older children and adults) vaccine | 1 | >Y65 | Adults | Every 10 years to travellers, occupational hazard workers, adults |
| TD_STd (Tetanus toxoid and diphtheria for older children and adults) vaccine | 1 | >=Y16 | Risk group(s) | Every 10 years to travellers, occupational hazard workers, adults |
| TD_STd (Tetanus toxoid and diphtheria for older children and adults) vaccine | 1 | >=Y16 | Travellers | Every 10 years to travellers, occupational hazard workers, adults |
| TD_STd (Tetanus toxoid and diphtheria for older children and adults) vaccine | 2 | +Y10 | Adults | Every 10 years to travellers, occupational hazard workers, adults |
| TD_STd (Tetanus toxoid and diphtheria for older children and adults) vaccine | 2 | +Y10 | Risk group(s) | Every 10 years to travellers, occupational hazard workers, adults |
| TD_STd (Tetanus toxoid and diphtheria for older children and adults) vaccine | 2 | +Y10 | Travellers | Every 10 years to travellers, occupational hazard workers, adults |
| TYPHOID_CONJTyphoid conjugate vaccine | 1 | 1st contact | Travellers | Travellers |
| TYPHOID_CONJTyphoid conjugate vaccine | 2 | +Y2 | Travellers | Travellers |
| VARICELLAVaricella vaccine | 1 | M24 | General/routine | |
| VARICELLAVaricella vaccine | 2 | Y4-Y6 | General/routine | |
| YFYF (Yellow fever) vaccine | 1 | 1st contact | Travellers | Travellers - Once in a lifetime |
| ZOSTERShingles (Herpes zoster for older adults) vaccine | 1 | Y50 | Risk group(s) | on referral |
| ZOSTERShingles (Herpes zoster for older adults) vaccine | 2 | +M2 | Risk group(s) | on referral |
Compare schedules across 31 countries on the schedule hub.
Data and sources
- Download this country's data (JSON): every year, every antigen and disease, with the grade reasons.
- Coverage: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) and country-reported administrative/official coverage, from the WHO Immunization Data Portal export downloaded 21 October 2026.
- Reported cases and incidence: WHO/UNICEF Joint Reporting Form, same export. Incidence denominators are stated per row.
- Schedule: WHO vaccine-schedule export, latest listing year.